Go to symposium website → www.slas.org/HighContentAnalysis
avatar for Gregory Vladimer, Ph.D.

Gregory Vladimer, Ph.D.

Gregory Vladimer is the CSO of Allcyte, a startup in Vienna, Austria. He received his PhD from UMass Medical School where he studied inflammation, and was a Senior Postdoctoral Fellow at CeMM in Vienna. Together with the Department of Hematology of the MedUniWien, spearheaded the use of single-cell image-based screening for the personalized identification of treatments for hematological cancers through a prospective clinical trial, and several retrospective studies. His work is published in journals including Nature, Lancet-Hematology, NEJM, and Cell, and he is on the steering-committee for the precision haematology working group of EHA advocating for standards around functional testing.